These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6366723

  • 1. The effect of small but sustained elevations in circulating growth hormone on fuel metabolism in growth hormone deficiency.
    Tamborlane WV, Genel M, Gianfredi S, Gertner JM.
    Pediatr Res; 1984 Feb; 18(2):212-5. PubMed ID: 6366723
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M, Oeckler R, Schopohl J, Müller OA, Alba-Lopez J, von Werder K.
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [Abstract] [Full Text] [Related]

  • 7. Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients.
    Laursen T, Jørgensen JO, Orskov H, Møller J, Harris AG, Christiansen JS.
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):399-408. PubMed ID: 7506470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
    Barkan AL, Beitins IZ, Kelch RP.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
    [Abstract] [Full Text] [Related]

  • 11. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ, Plöckinger U.
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of treated acromegalic patients with normal growth hormone levels during oral glucose load.
    Rieu M, Kuhn JM, Bricaire H, Luton JP.
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):1-8. PubMed ID: 6435366
    [Abstract] [Full Text] [Related]

  • 13. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.
    Fowelin J, Attvall S, Lager I, Bengtsson BA.
    Metabolism; 1993 Nov; 42(11):1443-7. PubMed ID: 8231841
    [Abstract] [Full Text] [Related]

  • 14. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC, Oldfield E, Loriaux DL, Merriam GR.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [Abstract] [Full Text] [Related]

  • 15. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C, Frystyk J, Kaal A, Laursen T, Møller J, Weeke J, Jørgensen JO, Sandahl Christiansen J, Orskov H.
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):25-33. PubMed ID: 10651750
    [Abstract] [Full Text] [Related]

  • 16. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
    Jørgensen JO, Møller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
    [Abstract] [Full Text] [Related]

  • 17. Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients.
    Laursen T, Møller J, Jørgensen JO, Orskov H, Christiansen JS.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):333-9. PubMed ID: 8949572
    [Abstract] [Full Text] [Related]

  • 18. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
    Jørgensen JO, Flyvbjerg A, Lauritzen T, Alberti KG, Orskov H, Christiansen JS.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):36-40. PubMed ID: 3288652
    [Abstract] [Full Text] [Related]

  • 19. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
    Bülow B, Erfurth EM.
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
    [Abstract] [Full Text] [Related]

  • 20. Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with sandostatin (SMS 201-995).
    Lamberts SW, Uitterlinden P, Verleun T.
    Eur J Clin Invest; 1987 Aug; 17(4):354-9. PubMed ID: 2889603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.